Business Description
Fresenius Medical Care AG
ISIN : US3580291066
Share Class Description:
FMS: ADRTotal Employee Number:
108,165Compare
Compare
Traded in other countries / regions
FME.GermanyFMS.USA0H9X.UKFME N.MexicoFME.Austria1FME.ItalyFMSC34.BrazilFME.Switzerland IPO Date
1996-09-17Description
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 3.23 | |||||
Interest Coverage | 4.77 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.79 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.6 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 7.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.54 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.17 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.64 | |||||
9-Day RSI | 60.71 | |||||
14-Day RSI | 58.81 | |||||
3-1 Month Momentum % | -2 | |||||
6-1 Month Momentum % | -6.93 | |||||
12-1 Month Momentum % | -21.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 54.01 | |||||
Days Sales Outstanding | 63.15 | |||||
Days Payable | 21.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.7 | |||||
Dividend Payout Ratio | 0.37 | |||||
3-Year Dividend Growth Rate | 2.2 | |||||
Forward Dividend Yield % | 3.7 | |||||
5-Year Yield-on-Cost % | 3.91 | |||||
3-Year Average Share Buyback Ratio | 1.6 | |||||
Shareholder Yield % | 10.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.96 | |||||
Operating Margin % | 9.41 | |||||
Net Margin % | 4.88 | |||||
EBITDA Margin % | 17.67 | |||||
FCF Margin % | 9.24 | |||||
OCF Margin % | 14.2 | |||||
ROE % | 7.03 | |||||
ROA % | 3 | |||||
ROIC % | 5.04 | |||||
3-Year ROIIC % | -7.64 | |||||
ROC (Joel Greenblatt) % | 22.1 | |||||
ROCE % | 7.26 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.35 | |||||
Forward PE Ratio | 7.79 | |||||
PE Ratio without NRI | 10.43 | |||||
Shiller PE Ratio | 9.96 | |||||
Price-to-Owner-Earnings | 5.97 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 0.84 | |||||
Price-to-Free-Cash-Flow | 6.7 | |||||
Price-to-Operating-Cash-Flow | 4.33 | |||||
EV-to-EBIT | 11.38 | |||||
EV-to-Forward-EBIT | 11.48 | |||||
EV-to-EBITDA | 6.17 | |||||
EV-to-Forward-EBITDA | 6.4 | |||||
EV-to-Revenue | 1.09 | |||||
EV-to-Forward-Revenue | 1.03 | |||||
EV-to-FCF | 11.8 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 0.41 | |||||
Price-to-Median-PS-Value | 0.58 | |||||
Earnings Yield (Greenblatt) % | 8.79 | |||||
FCF Yield % | 16.41 | |||||
Forward Rate of Return (Yacktman) % | 9.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:FMS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius Medical Care AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22,528.41 | ||
| EPS (TTM) ($) | 1.912 | ||
| Beta | 1.0281 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.09 | ||
| Volatility % | 18.2 | ||
| 14-Day RSI | 58.81 | ||
| 14-Day ATR ($) | 0.502266 | ||
| 20-Day SMA ($) | 22.963 | ||
| 12-1 Month Momentum % | -21.66 | ||
| 52-Week Range ($) | 20.02 - 28.19 | ||
| Shares Outstanding (Mil) | 537.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fresenius Medical Care AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fresenius Medical Care AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 122 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-03 | In 119 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 31 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 | In 28 days | ||
| USD 0.871575 Cash Dividend | 2026-05-22 | 22.50 (+1.21%) | ||
| General meeting for 2026 | 2026-05-21 | 22.20 (+0.77%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 21.65 (+0.51%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 08:00 | 22.65 (+0.58%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 23.41 (+1.74%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-24 08:00 | 24.59 (+0.37%) |
Show
Entries
Fresenius Medical Care AG Frequently Asked Questions
What is Fresenius Medical Care AG(FMS)'s stock price today?
The current price of FMS is $23.61. The 52 week high of FMS is $28.19 and 52 week low is $20.02.
When is next earnings date of Fresenius Medical Care AG(FMS)?
The next earnings date of Fresenius Medical Care AG(FMS) is 2026-08-07.
Does Fresenius Medical Care AG(FMS) pay dividends? If so, how much?
The Dividend Yield %  of Fresenius Medical Care AG(FMS) is 3.7% (As of Today), Highest Dividend Payout Ratio of Fresenius Medical Care AG(FMS) was 0.51. The lowest was 0.22. And the median was 0.34. The  Forward Dividend Yield % of Fresenius Medical Care AG(FMS) is 3.7%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:FMS
No articles.
Press Release
Articles on Fresenius Medical Care AG
No articles.
Headlines
See More- 1
Jun 22, 2026
Unicycive seeks to distinguish OLC in crowded CKD hyperphosphatemia market
Seeking Alpha • 8:56am
Jun 09, 2026
Lockheed Martin wins $153.9M deal for 11 F-35 aircraft long-lead parts
Seeking Alpha • 4:12pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers